Lonza 384 StellARray Alzheimer’s disease qPCR array

Friday, 04 February, 2011 | Supplied by: Lonza Australia Pty Ltd



The 384 StellARray qPCR array is designed to profile the expression pattern of genes that may increase susceptibility, contribute towards the progression or provide a neuroprotective role in Alzheimer’s disease.

It measures genes involved in amyloid peptide processing and degradation, formation of protein aggregates, neuroinflammation, apoptosis and neuronal survival. Many genes in this array are known to have altered expression in patients with Alzheimer’s disease.

Also included is an important subset of genes expressed in the blood that has been recently shown to classify and predict Alzheimer’s disease.

Primer pairs are designed to detect both RNA (as cDNA) and genomic DNA in separate assays, which enables analysis of both gene expression and genomic DNA copy-number variations (CNV) derived from the same primer pairs.

The assay is wet-lab validated and selected to yield single peak melt curves. Strict manufacturing QA/QC procedures are used to ensure consistency of performance.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

BioGX Xfree COVID-19 Direct RT-PCR test

The Xfree COVID-19 Direct RT-PCR test is a complete test in a single vial, lyophilised...

Bio-Rad Laboratories CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems

Bio-Rad Laboratories' CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems are suitable for...

PCR Biosystems NGSBIO Library Quant Kit for Illumina

The kit contains all the components necessary for sensitive quantification of DNA libraries prior...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd